diet
tradit
advoc
drug
reduc
risk
cardiovascular
diseas
statin
commonli
use
drug
prevent
cardiovascular
diseas
develop
specif
inhibit
cholesterol
synthesi
numer
studi
document
effect
reduc
serum
cholesterol
also
incid
coronari
heart
diseas
chd
scandinavian
simvastatin
surviv
studi
group
down
et
al
heart
protect
studi
collabor
group
shepherd
et
al
sack
et
al
herrington
et
al
interest
class
drug
extend
pleiotrop
effect
includ
antiinflammatori
action
typic
focus
reduct
creactiv
protein
crp
marker
inflamm
ridker
et
al
inflamm
consid
mani
play
key
role
cardiovascular
diseas
rifai
ridker
crp
propos
import
biomark
chd
risk
ridker
et
al
concern
use
diet
reduc
chd
risk
cholesterol
reduct
gener
small
compar
achiev
statin
evid
current
use
cholesterollow
diet
antiinflammatori
effect
recent
demonstr
parallel
studi
involv
subject
use
combin
cholesterollow
food
mark
reduct
serum
cholesterol
could
achiev
jenkin
et
al
diet
also
appear
reduc
crp
jenkin
et
al
origin
subject
subject
taken
three
treatment
control
statin
combin
diet
random
crossov
design
allow
effect
statin
compar
directli
combin
diet
taken
subject
detail
lipid
result
subject
separ
public
jenkin
et
al
report
document
direct
comparison
subject
chang
crp
follow
control
statin
portfolio
treatment
total
healthi
hyperlipidem
particip
complet
three
phase
studi
control
statin
portfolio
men
postmenopaus
women
age
rang
bodi
mass
index
bmi
rang
particip
baselin
characterist
shown
tabl
particip
recruit
hyperlipidem
patient
attend
clinic
nutrit
risk
factor
modif
center
st
michael
hospit
newspap
advertis
four
particip
random
start
studi
seven
particip
withdrawn
withdrew
follow
control
treatment
respect
figur
statin
portfolio
treatment
seven
three
particip
five
particip
could
begin
third
phase
studi
due
precaut
undertaken
minim
exposur
sever
acut
respiratori
syndrom
sar
viru
figur
particip
previous
rais
ldlcholesterol
level
mmoll
expert
panel
detect
evalu
treatment
high
blood
cholesterol
adult
particip
histori
cardiovascular
diseas
untreat
hypertens
blood
pressur
mmhg
diabet
renal
liver
diseas
none
take
medic
known
influenc
serum
lipid
apart
three
women
stabl
dose
thyroxin
one
also
take
stabl
estrogen
replac
therapi
particip
complet
treatment
particip
place
statin
discontinu
least
week
prior
treatment
period
five
particip
take
antihypertens
medic
constant
dose
prior
studi
seven
particip
took
aspirin
nonsteroid
antiinflammatori
drug
studi
regular
basi
particip
cold
flu
like
episod
immedi
time
blood
sampl
five
subject
suffer
hard
soft
tissu
injuri
osteoarthr
tendon
occasion
use
analges
antiinflammatori
drug
studi
conduct
late
summer
fall
winter
month
earli
spring
avoid
summer
holiday
travel
follow
random
crossov
design
three
treatment
separ
week
washout
period
treatment
particip
follow
lowsaturatedfat
therapeut
diet
month
prior
start
studi
week
washout
period
treatment
random
start
either
lowsaturatedfat
dairi
wholewheat
cereal
diet
statin
statin
without
statin
control
similarli
lowsaturatedfat
diet
contain
viscou
fiber
plant
sterol
soy
food
almond
portfolio
food
provid
except
fresh
fruit
veget
fast
bodi
weight
check
weekli
blood
sampl
obtain
crp
measur
h
overnight
fast
week
sevenday
diet
histori
obtain
week
prior
treatment
period
complet
menu
checklist
return
weekli
interv
onemonth
diet
period
check
dietitian
also
record
previou
week
exercis
encourag
particip
maintain
constant
level
activ
studi
period
statistician
whose
locat
geograph
separ
clinic
random
particip
use
pseudorandom
number
gener
facil
within
sa
statist
softwar
packag
sa
institut
statistician
held
code
placebo
lovastatin
capsul
ident
appear
provid
control
statin
treatment
respect
aspect
studi
therefor
doubl
blind
tablet
provid
portfolio
phase
dietitian
blind
diet
sinc
respons
pack
patient
diet
check
diet
record
laboratori
staff
respons
analys
blind
treatment
receiv
sampl
label
name
code
date
ethic
committe
univers
toronto
st
michael
hospit
approv
studi
written
inform
consent
obtain
particip
prior
studi
particip
ate
routin
therapeut
lowfat
diet
mean
macronutri
profil
close
current
ncep
guidelin
energi
satur
fat
mgd
dietari
cholesterol
expert
panel
detect
evalu
treatment
high
blood
cholesterol
adult
tabl
weightmaintain
diet
provid
studi
period
diet
vegetarian
aim
portfolio
diet
provid
g
plant
sterol
per
kcal
diet
plant
sterol
ester
enrich
margarin
g
viscou
fiber
per
kcal
diet
oat
barley
psyllium
g
soy
protein
per
kcal
soy
milk
soy
meat
analogu
g
whole
almond
per
kcal
diet
dietari
portfolio
describ
detail
previous
jenkin
et
al
skim
milk
fatfre
chees
yoghurt
egg
substitut
liquid
egg
white
use
control
diet
achiev
low
satur
fat
intak
high
fiber
intak
provid
whole
wheat
breakfast
cereal
g
kcal
bread
g
kcal
wheat
bran
ad
high
dairi
protein
muffin
g
kcal
diet
high
monounsatur
fatti
acid
sunflow
oil
kcal
safflow
oil
kcal
also
incorpor
control
diet
eg
muffin
balanc
fatti
acid
profil
portfolio
diet
macronutri
profil
diet
record
consum
week
given
tabl
complianc
assess
complet
weekli
checklist
return
uneaten
food
item
twenti
mg
lovastatin
placebo
capsul
lactos
dispens
hospit
pharmaci
ident
contain
accord
random
determin
statistician
particip
ask
take
one
capsul
mg
lovastatin
placebo
daili
even
day
studi
return
contain
capsul
count
end
month
sampl
given
individu
label
code
analyz
batch
serum
sampl
store
analyz
crp
endpoint
nephelometri
coeffici
variat
behr
n
highsensit
crp
reagent
dadebehr
mississauga
ontario
canada
diet
analyz
use
program
base
us
depart
agricultur
data
develop
laboratori
jenkin
et
al
result
express
signific
differ
blood
crp
seen
week
valu
week
valu
therefor
use
throughout
analys
end
point
valu
signific
differ
treatment
assess
least
squar
mean
adjust
multipl
comparison
sa
institut
anova
model
use
absolut
crp
reduct
well
percentag
chang
baselin
respons
variabl
treatment
sex
sex
treatment
interact
random
particip
term
nest
within
sex
sequenc
main
effect
absolut
crp
reduct
also
assess
use
ancova
model
baselin
covari
minim
risk
includ
subject
may
transient
elev
crp
due
infect
injuri
primari
analysi
elimin
valu
mgl
sinc
recent
analysi
studi
measur
crp
men
women
percentil
women
mgl
men
valu
mgl
ocken
et
al
rifai
ridker
distribut
respons
far
normal
extrem
departur
normal
bia
result
ftest
neter
et
al
data
transform
obtain
normal
sampl
distribut
achiev
twoparamet
famili
transform
box
cox
use
appli
grid
search
procedur
maxim
statist
statist
appli
often
test
hypothesi
underli
normal
distribut
special
macro
written
use
sa
softwar
sa
institut
inc
cari
nc
usa
estim
paramet
transform
secondari
analysi
also
carri
includ
particip
complet
least
one
two
three
phase
three
nine
particip
respect
part
intent
treat
analysi
increas
total
number
subject
control
statin
portfolio
respect
analysi
includ
subject
post
baselin
valu
includ
two
subject
whose
week
valu
carri
forward
week
wilcoxon
sign
rank
test
use
assess
signific
chang
pretreat
nonparametr
sign
test
use
assess
whether
statin
portfolio
diet
significantli
differ
reduc
crp
complet
intent
treat
analysi
total
group
includ
noncomplet
spearman
correl
use
assess
associ
crp
anthropometr
data
due
skew
nonnorm
distribut
crp
data
sa
institut
data
analyz
three
time
first
complet
data
subsequ
basi
result
two
post
hoc
analys
aim
post
hoc
analys
determin
effect
reduc
scatter
seen
crp
often
relat
acut
infect
nondiet
relat
event
analys
maximum
level
mgl
commonli
accept
upper
level
ocken
et
al
mgl
larg
metaanalysi
rifai
ridker
use
upper
level
valu
inclus
differ
seen
three
treatment
group
baselin
crp
measur
signific
treatment
differ
observ
use
data
point
howev
analysi
restrict
crp
valu
mgl
subject
complet
three
phase
figur
absolut
reduct
baselin
week
signific
statin
portfolio
mgl
mgl
respect
control
mgl
express
percentag
baselin
valu
respect
chang
control
statin
portfolio
respect
tabl
includ
also
noncomplet
control
statin
portfolio
diet
absolut
chang
baselin
mgl
mgl
mgl
respect
express
percentag
baselin
valu
respect
chang
absolut
reduct
percentag
reduct
baselin
crp
significantli
greater
portfolio
control
treatment
respect
use
anova
model
differ
statin
control
reach
signific
absolut
reduct
percentag
chang
statin
portfolio
treatment
similar
absolut
reduct
percentag
chang
similar
result
obtain
use
ancova
model
baselin
covari
data
present
sinc
data
analyz
three
time
first
complet
data
also
elimin
crp
valu
greater
mgl
mgl
bonferroni
adjust
critic
level
p
appli
assess
signific
three
comparison
comparison
signific
bonferroni
adjust
p
greater
percentag
reduct
baselin
crp
portfolio
compar
control
treatment
use
data
mgl
differ
observ
sex
respons
treatment
sinc
signific
interact
effect
sex
treatment
found
women
portfolio
treatment
absolut
reduct
crp
significantli
greater
control
treatment
statin
nonsignific
men
neither
differ
statin
control
portfolio
control
reach
signific
respect
use
week
week
data
complet
exclud
crp
valu
mgl
portfolio
treatment
significantli
effect
control
diet
reduc
blood
crp
show
neg
valu
chang
week
control
diet
portfolio
statin
portfolio
treatment
similarli
effect
statin
addit
incomplet
studi
particip
complet
one
two
three
phase
gave
similar
result
particip
complet
three
phase
total
number
particip
undertook
control
statin
portfolio
phase
crp
mgl
increas
particip
respect
portfolio
treatment
effect
control
diet
reduc
blood
crp
statin
portfolio
treatment
similarli
effect
control
diet
statin
portfolio
use
complet
data
subject
week
three
treatment
crp
significantli
relat
baselin
bmi
tabl
similar
result
obtain
crp
mgl
exclud
signific
associ
crp
signific
associ
chang
crp
chang
bmi
tabl
crp
valu
greater
mgl
ie
mgl
repres
percentil
week
valu
greater
mgl
incid
associ
document
infect
joint
pain
soft
tissu
injuri
immedi
time
blood
sampl
without
use
analges
antiinflammatori
drug
respect
percentag
crp
valu
less
mgl
incid
data
demonstr
diet
shown
effect
lower
serum
cholesterol
also
lower
crp
extent
statin
taken
individu
reduct
crp
lovastatin
studi
similar
report
larg
studi
lovastatin
use
ridker
et
al
crp
accept
nonlipid
risk
factor
heart
diseas
dietari
reduct
crp
provid
evid
addit
benefit
cholesterol
lower
diet
reduc
chd
risk
present
unlik
ldlcholesterol
prospect
studi
design
specif
lower
crp
shown
reduc
incid
cardiovascular
event
situat
therefor
similar
homocystein
strong
associ
demonstr
cardiovascular
diseas
homocystein
studi
collabor
result
larg
random
control
trial
yet
avail
provid
definit
evid
caus
effect
relat
present
strong
associ
crp
cardiovascular
diseas
ridker
et
al
especi
women
ridker
et
al
appear
power
predict
valu
similar
ldlcholesterol
hdlcholesterol
ratio
ridker
et
al
furthermor
larg
reduct
chd
risk
statin
seen
subject
normal
ldlcholesterol
level
high
crp
level
baselin
ridker
et
al
increas
bodi
weight
central
adipos
insulin
resist
associ
rais
crp
level
ford
yudkin
et
al
lemieux
et
al
present
studi
bmi
baselin
one
determin
crp
link
presum
adipos
tissuederiv
proinflammatori
cytokin
eg
effect
hepat
acut
phase
protein
rattazzi
et
al
howev
one
concern
crp
potenti
predict
valu
chd
control
physiolog
noncardiovascular
patholog
variat
crp
variabl
also
like
explan
statin
trial
shown
reduc
crp
concentr
danga
et
al
cortellaro
et
al
kalela
et
al
crp
concentr
increas
infect
tillet
franci
ledu
rifai
estrogen
ridker
et
al
pradhan
et
al
influenc
lifestyl
manipul
includ
alcohol
intak
regular
exercis
tend
depress
crp
cushman
et
al
albert
et
al
smoke
may
increas
albert
et
al
frohlich
et
al
although
mani
factor
also
associ
chd
risk
may
therefor
contribut
overal
use
crp
acut
chang
may
reduc
predict
valu
crp
seen
cohort
studi
danesh
et
al
tall
confound
shortterm
intervent
studi
one
respect
may
noteworthi
phase
two
three
present
studi
carri
winter
month
spring
phase
one
also
focu
previou
studi
show
clearer
effect
dietari
portfolio
lower
crp
carri
larg
late
summer
fall
may
unreport
respiratori
infect
common
winter
may
result
increas
variabl
crp
data
reflect
current
analysi
present
studi
well
compli
term
percentag
tablet
taken
dietari
calori
report
consum
addit
rel
uniform
reduct
ldlcholesterol
seen
week
statin
portfolio
treatment
jenkin
et
al
present
studi
advantag
alcohol
intak
limit
prestudi
period
allow
metabol
diet
exercis
also
held
constant
throughout
studi
period
one
subject
smoke
cigarett
daili
studi
period
nevertheless
despit
precaut
use
unrestrict
crp
data
treatment
effect
observ
order
obtain
suffici
definit
establish
effect
statin
dietari
portfolio
crp
necessari
elimin
valu
exceed
mgl
valu
select
percentil
pool
analysi
physician
health
studi
ph
air
forcetexa
coronari
atherosclerosi
prevent
studi
afcapstexcap
women
health
initi
whi
women
health
studi
wh
ocken
et
al
percentil
group
men
women
current
american
heart
associ
center
diseas
control
recommend
crp
part
assess
cardiovascular
diseas
risk
mgl
low
risk
mgl
intermedi
risk
mgl
high
risk
pearson
et
al
studi
therefor
cover
intermedi
risk
rang
subject
valu
greater
mgl
reason
flu
like
ill
infect
tissu
injuri
rais
crp
compar
individu
valu
less
mgl
respect
valu
studi
mgl
upper
level
crp
jenkin
et
al
subject
valu
mgl
ocken
et
al
studi
much
inclus
defin
infect
may
associ
rais
crp
level
includ
infect
occur
day
prior
blood
sampl
pischon
et
al
data
like
underestim
effect
infect
increas
rang
littl
week
prior
blood
sampl
would
increas
percentag
rais
crp
level
could
account
previou
studi
demonstr
effect
diet
crp
recent
veget
oil
monounsatur
fat
shown
reduc
crp
low
glycem
index
diet
pischon
et
al
blok
et
al
liu
et
al
soy
isoflavon
appear
increas
although
signific
increas
crp
report
jenkin
et
al
almond
appear
influenc
crp
concentr
jenkin
et
al
data
report
fiber
plant
sterol
crp
exact
reason
portfolio
dietari
compon
use
appear
reduc
crp
level
present
provid
carbohydr
food
dietari
portfolio
tend
low
glycem
indic
includ
oat
bran
fosterpowel
et
al
barley
fosterpowel
et
al
viscou
fiber
psyllium
also
reduc
postprandi
glycemia
jenkin
et
al
suggest
reduc
postprandi
glycemia
insulinemia
turn
result
less
free
radic
gener
oxid
stress
ceriello
motz
less
cytokin
releas
adipos
tissu
includ
tumor
necrosi
adipos
tissuederiv
cytokin
stimul
hepat
acut
phase
protein
product
lead
increas
serum
level
crp
serum
amyloid
recent
studi
suggest
link
consumpt
low
glycem
index
diet
reduc
plasma
crp
correl
wolev
et
al
conclus
diet
combin
number
cholesterollow
food
may
also
lower
crp
similar
extent
statin
crp
reduct
shown
reduc
chd
risk
independ
biochem
chang
action
dietari
portfolio
would
reason
might
reduc
chd
risk
